Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis - 03/12/20
Doi : 10.1016/j.jaci.2020.07.031
Matthew Greenhawt, MD, MBA, MSc a, ⁎ 
, Marcus Shaker, MD, MS b, Julie Wang, MD c, John J. Oppenheimer, MD d, Scott Sicherer, MD c, Corinne Keet, MD, PhD e, Keri Swaggart, MLIS f, Matthew Rank, MD g, h, Jay M. Portnoy, MD i, Jonathan Bernstein, MD j, Derek K. Chu, MD, PhD k, l, Chitra Dinakar, MD m, David Golden, MD n, Carolyn Horner, MD o, David M. Lang, MD p, Eddy S. Lang, MD q, David A. Khan, MD r, Jay Lieberman, MD s, David Stukus, MD t, Dana Wallace, MD u
, Marcus Shaker, MD, MS b, Julie Wang, MD c, John J. Oppenheimer, MD d, Scott Sicherer, MD c, Corinne Keet, MD, PhD e, Keri Swaggart, MLIS f, Matthew Rank, MD g, h, Jay M. Portnoy, MD i, Jonathan Bernstein, MD j, Derek K. Chu, MD, PhD k, l, Chitra Dinakar, MD m, David Golden, MD n, Carolyn Horner, MD o, David M. Lang, MD p, Eddy S. Lang, MD q, David A. Khan, MD r, Jay Lieberman, MD s, David Stukus, MD t, Dana Wallace, MD u a Section of Allergy and Immunology, Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo
b Section of Allergy and Immunology, Dartmouth-Hitchcock Medical Center, Dartmouth Geisel School of Medicine, Lebanon, NH
c Division of Pediatric Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai and the Jaffe Food Allergy Institute, New York, NY
d Department of Internal Medicine, New Jersey Medical School, Morristown, NJ
e Division of Pediatric Allergy and Immunology, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Md
f Library Services, Children's Mercy Hospital, Kansas City, Mo
g Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz
h Division of Pulmonology, Phoenix Children's Hospital, Phoenix, Ariz
i Division of Allergy, Asthma & Immunology, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Mo
j Division of Immunology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio
k Department of Health Research Methods, Evidence & Impact, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
l The Research Institute of St. Joe's Hamilton, Hamilton, Ontario, Canada
m Division of Allergy and Asthma, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, Calif
n Department of Allergy-Clinical Immunology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Md
o Division of Allergy, Immunology, and Pulmonary Medicine, Washington University School of Medicine, St Louis, Mo
p Department of Allergy and Clinical Immunology, Cleveland Clinic, Cleveland, Ohio
q Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
r Division of Allergy & Immunology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Tex
s Division of Allergy and Immunology, Department of Pediatrics, The University of Tennessee, Memphis, Tenn
t Division of Allergy and Immunology, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio
u Nova Southeastern University College of Allopathic Medicine, Fort Lauderdale, Fla
∗Corresponding author: Matthew Greenhawt, MD, MBA, MSc, Section of Allergy and Immunology, Food Challenge and Research Unit, Children's Hospital Colorado, University of Colorado School of Medicine, 13123 E. 16th Avenue, Aurora, CO 80045.Section of Allergy and ImmunologyFood Challenge and Research UnitChildren's Hospital ColoradoUniversity of Colorado School of Medicine13123 E. 16th AvenueAuroraCO80045
Abstract |
Given the burden of disease and the consequences of a diagnosis of peanut allergy, it is important that peanut allergy be accurately diagnosed so that an appropriate treatment plan can be developed. However, a test that indicates there is peanut sensitization present (eg, a “positive” test) is not always associated with clinical reactivity. This practice parameter addresses the diagnosis of IgE-mediated peanut allergy, both in children and adults, as pertaining to 3 fundamental questions, and based on the systematic reviews and meta-analyses, makes recommendations for the clinician who is evaluating a patient for peanut allergy. These questions relate to when diagnostic tests should be completed, which diagnostic tests to utilize, and the utility (or lack thereof) of diagnostic testing to predict the severity of a future allergic reaction to peanut.
El texto completo de este artículo está disponible en PDF.Key words : Peanut allergy, diagnosis, practice parameter update, systematic review, GRADE analysis, Ara h 2, peanut components, skin prick testing, serologic IgE testing, likelihood ratio, evidence to recommendation, meta-analysis, cost-effectiveness analysis
Abbreviations used : AAAAI, ACAAI, AMSTAR, FPIES, GRADE, JTFPP, KUA, NIAID, OFC, PICO, PPV, PRISMA, sIgE, SPT
Esquema
| Disclosure of potential conflict of interest: The Joint Task Force on Practice Parameters (JTFPP) members’ and work group members’ conflict of interest disclosure forms can be found at www.allergyparameters.org. Matthew Greenhawt has received financial support from Aquestive, Aimmune, Merck, Allergenis, Allergy Therapeutics, Sanofi Genzyme, Genentech, GlaxoSmithKline, Merck, Aravax, Prota, Before Brands, the Institute for Clinical and Economic Review, American College of Asthma, Allergy, and Immunology, DBV Technologies, and Intrommune; is supported by the Agency of Healthcare Research and Quality; has served on the advisory board of International Food Protein Induced Enterocolitis Syndrome Association, the Asthma and Allergy Foundation of America, and the National Peanut Board; and is Associate Editor of the Annals of Allergy, Asthma, and Immunology. Marcus Shaker is a member of the Joint Task Force on Allergy Practice Parameters; has a family member who is chief executive officer of Altrix Medical; and serves on the Editorial Board of the Journal of Food Allergy and the Annals of Allergy, Asthma, and Immunology. Julie Wang has received financial support from ALK-Abelló, Regeneron, DBV Technologies, and Aimmune; is an UpToDate author; serves on the Executive Committee of the American Academy of Pediatrics Section on Allergy and Immunology; and serves as Vice Chair of the American Academy of Allergy, Asthma, and Immunology (AAAAI) Anaphylaxis, Dermatitis, Drug Allergy Interest Section. John J. Oppenheimer has received financial support from DBV Technologies, TEVA, GlaxoSmithKline Adjudication/Data Safety Monitoring Board, AstraZeneca, Novartis, and Sanofi; and is Associate Editor of the Annals of Allergy, Asthma, and Immunology and AllergyWatch, an American Board of Internal Medicine (ABIM) Council Member, and American Board of Allergy and Immunology Liaison to the ABIM, UpToDate Reviewer, American College of Chest Physicians Cough Guideline Committee Member, and WebMD Editor. Scott Sicherer has received financial support from Food Allergy Research and Education Clinical Center, John Hopkins University Press, HAL Allergy Group, AAAAI, UpToDate, and National Institutes of Allergy and Infectious Disease; and is a Medical Advisor at International Food Protein Induced Enterocolitis Syndrome Association and member of the Executive Committee at the American Academy of Pediatrics. Corinne Keet received royalties from UpToDate; is an Associate Editor for the Journal of Allergy and Clinical Immunology; and is a Board Member for the American Board of Allergy and Immunology. Matthew Rank has received financial support from the American College of Asthma, Allergy, and Immunology (ACAAI), National Institutes of Health, and Levin Family Foundation; has served as Chair of the AAAAI Health Education Delivery and Quality (HEDQ) Interest Section; and is Research Director of the Phoenix Children’s Hospital Breathmobile. Jay M. Portnoy has received financial support from Thermo Fisher Scientific, Kaleo, TEVA, Novartis, Hycor, and Boehringer-Ingelheim. Jonathan Bernstein has received financial support from Sanofi Regeneron, AstraZeneca, Merck, Optinose, Takeda, CSL Behring, Biocryst, Pharming, the National Institutes of Health, Taylor and Francis, and INEOS; is Editor-in-Chief of the Journal of Asthma, INEOS medical immunosurveillance director, Vice Chair and Lectureship Chair of the AAAAI Foundation, chairman of Allergists for Israel (AFI), ACAAI Asthma Chair, Scientific Chair, and Young Investigator Award Chair; and serves on the Board of Directors and Scientific Committee of Interasma. Derek K. Chu is a CAAIF-CSACI-AllerGen Emerging Clinician-Scientist Research Fellow; and is supported by the Canadian Allergy, Asthma and Immunology Foundation (CAAIF), the Canadian Society of Allergy and Clinical Immunology (CSACI), and AllerGen NCE Inc. (the Allergy, Genes and Environment Network). Chitra Dinakar has received financial support from Propeller Health, ACAAI (stipend for Editorial Board of AllergyWatch), and the American Association of Allergists of Indian Origin; serves on the Board of Directors of the AAAAI and on the Medical Advisory Board of Food Equity Initiative; and is Assistant Editor of AllergyWatch. David Golden has received financial support from Aquestive, Sandoz, ALK-Abelló, Genentech, Stallergenes-Greer, and UpToDate. Carolyn Horner has served as Committee Chair for the American Academy of Allergy, Asthma, and Asthma Diagnosis and Treatment Interest Section, Interest Section Coordinating Committee, and In-Training Exam Coordinating Committee. David M. Lang is on the Editorial Board for Allergy and Asthma Proceedings, Topic Editor for DynaMed, Associate Editor for Journal of Asthma, and Delegate to National Quality Forum representing the AAAAI. David A. Khan has received financial support from UpToDate and Aimmune; serves on the Board of Directors of the AAAAI; as ACAAI (Chair of Literature Review, as Co-Chair of Conjoint Board Review, and as Texas Allergy, Asthma, and Immunology Society Chair of Meetings Committee; and is Associate Editor of the Journal of Allergy and Clinical Immunology In Practice. Jay Lieberman has received financial support from the ACAAI, Aquestive, Aimmune, DBV Technologies, Biotest Pharma, and Regeneron; and is Associate Editor of the Annals of Allergy, Asthma, and Immunology, Vice Chair for the ACAAI Food Allergy Committee, and Medical Director for Food Allergy Alliance of the MidSouth. David Stukus has received financial support from Aimmune, Before Brands, Abbott Nutrition, the American Academy of Pediatrics, and ACAAI; and has served as Committee Chair for the AAAAI and ACAAI. Dana Wallace has received financial support from Mylan, Kaleo, Optinose, ALK-Abelló, Bryan, and Sanofi. The rest of the authors declare that they have no relevant conflicts of interest. |
|
| Reprints: JointTask Force on Practice Parameters Liaison: Peris Flagg (American Academy of Allergy, Asthma, and Immunology, 555 E. Wells Street, Suite 1100, Milwaukee, WI 53202. E-mail: pflagg@aaaai.org); JTFPP.allergy@gmail.com. |
|
| Previously published practice parameters of the JTFPP for allergy and immunology are also available at www.allergyparameters.org, www.AAAAI.org, and www.ACAAI.org. |
© 2020
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 146 - N° 6
P. 1302-1334 - décembre 2020 Regresar al número
Artículo precedente
- Asthma-associated risk for COVID-19 development
- Chrysanthi Skevaki, Antonina Karsonova, Alexander Karaulov, Min Xie, Harald Renz
- The Editors’ Choice
- Zuhair K. Ballas, Associate Editors of the JACI
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?